Ayurvedic treatment in the rehabilitation of ischemic stroke
ISRCTN | ISRCTN68137638 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN68137638 |
Secondary identifying numbers | RESTORE Protocol Version 1.2 dated 04 March 2020, CTRI/2018/04/013379 |
- Submission date
- 09/02/2023
- Registration date
- 16/03/2023
- Last edited
- 03/03/2023
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Plain English Summary
Background and study aims
After a stroke, two-thirds of the survivors have a functional disability that impairs their activities of daily living. Effective stroke rehabilitation remains an essential part of stroke care and leads to improvement in physical disability, better social life, employment, and quality of life. Conventional physiotherapy, a mainstream for stroke rehabilitation, is proven to be effective by several randomized controlled trials and systematic reviews. Because of its convenience and practicability, physiotherapy is frequently used to improve the functional recovery of stroke patients in the acute phase.
Ayurveda is a distinctive system of treatment that has been practised in India for stroke rehabilitation. There are no randomised controlled data available on its safety and effectiveness.
The study aims to determine the safety and effectiveness of Ayurvedic treatment in the rehabilitation of stroke patients and to compare the effectiveness of Ayurvedic treatment over conventional physiotherapy in the rehabilitation of stroke patients.
Who can participate?
Patients aged over 18 years and who had their first episode of ischemic stroke defined on CT scan or MRI brain and presentation between 1 month to 3 months of stroke onset
What does the study involve?
Participants are randomly allocated to the intervention group or the control group.
Participants allocated to the intervention group will receive Ayurveda treatment for 29 days as per the treatment protocol The treatment includes procedures like Dhanyamla Dhara, Ksheera Dhooma, Patrapodala Swedam (induced sweating), Virechana, Dhanya Pinda Swedam (induced sweating), and Madhu Tailika Vasti (medicated enema).
All patients in the control group will receive conventional physiotherapy. Physiotherapy intervention will be given 5 days per week for 5 weeks (25 days). The duration of therapy will be 1 hour per day. The intervention is delivered by the study physiotherapist either at home or at the outpatient unit. The physiotherapy treatment procedures include passive and/or active range of motion exercises, weight-bearing, and supportive reaction, reaching activities, grasping, holding, and release, upper extremity activities of daily living (ADLs); lower extremity ADLs, gait training, trunk exercises, and faciliatory exercises for upper limb and lower limbs.
What are the possible benefits and risks of participating?
There are no risks associated with participating in this study. The Ayurveda treatment involves only the routine ayurvedic procedures that are performed to improve the strength and vitality of individuals. Physiotherapy rehabilitation involves the widely accepted rehabilitation techniques performed on stroke patients. Patients might experience minor discomforts like mild pain with physiotherapy, mild pain, slight fatigue, and occasional stomach irritation with Ayurveda treatment.
The rehabilitation modalities (Ayurveda/physiotherapy) are expected to be beneficial in improving the recovery of patients from stroke. These rehabilitation strategies might help in improving the functional ability, ability to perform activities of daily living, and quality of life.
Where is the study run from?
1. Sree Chitra Tirunal Institute of Medical Sciences and Technology (India)
2. Christian Medical College & Hospital, Ludhiana, Punjab (India)
3. Amrita Institute of Medical Science, Kochi (India)
4. Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry (India)
When is the study starting and how long is it expected to run for?
March 2018 to November 2022
Who is funding the study?
Indian Council of Medical Research (India)
Who is the main contact?
Dr P N Sylaja, sylajapn@sctimst.ac.in
Contact information
Principal Investigator
Comprehensive Stroke Care Program, Department of Neurology
Sree Chitra Tirunal Institute of Medical Sciences and Technology
Thiruvananthapuram
695001
India
0000-0003-4896-8275 | |
Phone | +91 (0)4712524482 |
sylajapn@sctimst.ac.in |
Study information
Study design | Single-blinded randomized controlled blinded assessment (PROBE design) trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Home, Hospital |
Study type | Treatment |
Participant information sheet | Not available in web format |
Scientific title | Ayurvedic treatment in the rehabilitation of ischemic stroke patients in India: a randomized controlled trial |
Study acronym | RESTORE |
Study hypothesis | The study hypothesizes that Ayurvedic rehabilitative treatment is superior to similar duration conventional physiotherapy in improving the sensorimotor recovery of patients with ischemic stroke at 90 days after enrolment. Before the study initiation, the study was registered in the Clinical Trials Registry - India (CTRI) with registration number CTRI/2018/04/013379 dated 19/04/2018. |
Ethics approval(s) | Approved 02/07/2018, Institutional Ethics Committee, Sree Chitra Tirunal Institute for Medical Sciences and Technology (Trivandrum, Kerala - 695011, India; +91 (0)471-2524689; iec.mem.sec@sctimst.ac.in), ref: SCT/IEC/1183/JUNE 2018 |
Condition | Rehabilitation in ischemic stroke |
Intervention | The eligible patients will be randomized using a central, web-based, block randomization process to assign the study arm. The researcher randomizing the subjects at the participating centres (four centres) will receive the allocation status by entering the patient details in the randomization web portal (https://easyresearch.instructnetwork.in/EasyResearch/AribaWeb/). Eligible patients will be block randomized and stratified by the study centre in a 1:1 ratio to have a balance between the number of subjects in the intervention and the control arm. The patients allocated to the intervention arm will receive Ayurveda Rehabilitation Treatment (ART) for 29 days as per the treatment protocol. The treatment includes procedures like Dhanyamla Dhara, Ksheera Dhooma, Patrapodala Swedam (induced sweating), Virechana), Dhanya Pinda Swedam (induced sweating), and Madhu Tailika Vasti (medicated enema). The intervention is provided as an in-patient treatment at the ayurvedic centres and all intervention procedures will be performed under the direct supervision of an ayurvedic physician. All patients in the control group will receive conventional physiotherapy. Physiotherapy intervention will be given 5 days per week for 5 weeks (25 days). The duration of therapy will be 1 hour per day. The intervention is delivered by the study physiotherapist either at home or at the outpatient unit. The physiotherapy treatment procedures include passive and/or active range of motion exercises, weight-bearing, and supportive reaction, reaching activities, grasping, holding, and release, upper extremity activities of daily living (ADLs); lower extremity ADLs, gait training, trunk exercises, and faciliatory exercises for upper limb and lower limbs. The patients will be followed for a 1-month and 3-month period to assess sensorimotor function using efficacy outcome scales. |
Intervention type | Other |
Primary outcome measure | Sensorimotor recovery assessed using the Fugl Meyer Assessment – Upper Extremity (FMA - UE) scale at the time of recruitment (baseline), at 1 month, and 3 months from the baseline |
Secondary outcome measures | Measured at the time of recruitment (baseline), at 1 month, and 3 months from the baseline: 1. Functional disability assessed using the modified Rankin scale (mRS) 2. Postural balance assessed using the Berg Balance Scale (BBS) 3. Quality of life assessed using Short form 36 (SF 36) 4. Activities of daily living assessed using the Barthel index (BI) |
Overall study start date | 28/03/2018 |
Overall study end date | 30/11/2022 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 70 Years |
Sex | Both |
Target number of participants | 140 |
Total final enrolment | 140 |
Participant inclusion criteria | 1. First episode of ischemic stroke with a corresponding acute infarct observed on CT scan or MRI brain 2. Presentation between 1 month to 3 months of stroke symptom onset 3. Age group between 18-70 years 4. Modified Rankin Scale scores of 3 and 4 at the time of enrollment 5. Pre-stroke modified Rankin scale (mRS) less than or equal to 2 |
Participant exclusion criteria | 1. Bilateral symptomatic strokes 2. Intracerebral hemorrhage 3. Significant joint deformity preventing effective rehabilitation measures 4. Unstable cardiopulmonary status and other diseases which are likely to hamper effective rehabilitation (uncontrolled diabetes with HbA1c >8% or fasting blood glucose >130 mg/dl and postprandial blood glucose >180 mg/dl at the time of recruitment; history of hemorrhoids/rectal prolapse/anal fissure/anal fistula; allergic/infectious/ noninfectious skin disorders) 5. Current use of any other complementary and alternative therapy |
Recruitment start date | 22/05/2019 |
Recruitment end date | 19/07/2022 |
Locations
Countries of recruitment
- India
Study participating centres
Thiruvananthapuram
695011
India
Kochi
682041
India
Puducherry
605006
India
Ludhiana
141008
India
Sponsor information
Government
V. Ramalingaswami Bhawan, PO Box No. 4911
Ansari Nagar
New Delhi
110029
India
Phone | +91 (0)1126588895 |
---|---|
icmrhqds@sansad.nic.in | |
Website | http://www.icmr.nic.in/ |
https://ror.org/0492wrx28 |
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- Indian Council of Medical Research, Government of India, Indian Council of Medical Research (ICMR), New Delhi, ICMROrganisation, भारतीय चिकित्सा अनुसंधान परिषद, Indian Council of Medical Research, New Delhi, ICMR, ICMRDELHI, आई.सी.एम.आर
- Location
- India
Results and Publications
Intention to publish date | 30/06/2023 |
---|---|
Individual participant data (IPD) Intention to share | Yes |
IPD sharing plan summary | Available on request |
Publication and dissemination plan | The researchers have submitted the protocol and statistical analysis plan paper to a medium-impact peer-reviewed journal and intend to publish the main results paper within 3 months of completion of the study in a peer-reviewed high-impact journal. |
IPD sharing plan | The dataset generated during and/ or analyzed during the current study will be available upon request from Dr P N Sylaja (sylajapn@sctimst.ac.in). The type of data that will be shared: All the collected data Dates of availability: until 5 years after the end of the trial. Whether consent from participants was required and obtained: consent was required and was obtained. Comments on data anonymization: the names of the participants were anonymised. |
Editorial Notes
03/03/2023: Trial's existence confirmed by the Indian Council of Medical Research.